These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9000573

  • 1. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF, Hamilton RL, Finkelstein SD, Campbell JW, Martinez AJ, Sherwin RN, Bozik ME, Gollin SM.
    Cancer Res; 1997 Jan 15; 57(2):304-9. PubMed ID: 9000573
    [Abstract] [Full Text] [Related]

  • 2. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF, Finkelstein SD, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Finlay JL, Sposto R, Children's Cancer Group.
    Cancer Res; 2001 Oct 15; 61(20):7404-7. PubMed ID: 11606370
    [Abstract] [Full Text] [Related]

  • 3. Expression of p53 and prognosis in children with malignant gliomas.
    Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R, Children's Cancer Group.
    N Engl J Med; 2002 Feb 07; 346(6):420-7. PubMed ID: 11832530
    [Abstract] [Full Text] [Related]

  • 4. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M, Peraud A, Leroch B, Kreth FW.
    Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912
    [Abstract] [Full Text] [Related]

  • 6. Alterations of the TP53 gene in human gliomas.
    Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.
    Cancer Res; 1994 Mar 01; 54(5):1324-30. PubMed ID: 8118823
    [Abstract] [Full Text] [Related]

  • 7. Proliferation index as a predictor of prognosis in malignant gliomas of childhood.
    Pollack IF, Campbell JW, Hamilton RL, Martinez AJ, Bozik ME.
    Cancer; 1997 Feb 15; 79(4):849-56. PubMed ID: 9024724
    [Abstract] [Full Text] [Related]

  • 8. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM, Foekens JA, Vossen R, Look MP, Devilee P, Henzen-Logmans SC, van Staveren IL, van Putten WL, Inganäs M, Meijer-van Gelder ME, Cornelisse C, Claassen CJ, Portengen H, Bakker B, Klijn JG.
    Cancer Res; 2000 Apr 15; 60(8):2155-62. PubMed ID: 10786679
    [Abstract] [Full Text] [Related]

  • 9. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 15; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
    Bredel M, Pollack IF, Hamilton RL, James CD.
    Clin Cancer Res; 1999 Jul 15; 5(7):1786-92. PubMed ID: 10430083
    [Abstract] [Full Text] [Related]

  • 11. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan 15; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 12. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4067-73. PubMed ID: 15930341
    [Abstract] [Full Text] [Related]

  • 13. Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors.
    Addeo R, Crisci S, D'Angelo V, Vincenzi B, Casale F, Pettinato G, Donofrio V, Boldrini R, Alaggio R, Collini P, Bertorelle R, Di Tullio MT, Caraglia M, Terenziani M, Lo Curto M, Indolfi P.
    Oncol Rep; 2007 May 01; 17(5):1155-61. PubMed ID: 17390059
    [Abstract] [Full Text] [Related]

  • 14. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
    Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL.
    J Clin Oncol; 2006 Jul 20; 24(21):3431-7. PubMed ID: 16849758
    [Abstract] [Full Text] [Related]

  • 15. Prognostic relevance of p53 protein expression in glioblastoma.
    Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ungersböck K, Rössler K, Budka H, Hainfellner JA.
    Oncol Rep; 2002 Jul 20; 9(4):703-7. PubMed ID: 12066196
    [Abstract] [Full Text] [Related]

  • 16. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
    Geisler S, Lønning PE, Aas T, Johnsen H, Fluge O, Haugen DF, Lillehaug JR, Akslen LA, Børresen-Dale AL.
    Cancer Res; 2001 Mar 15; 61(6):2505-12. PubMed ID: 11289122
    [Abstract] [Full Text] [Related]

  • 17. Genetic analyses for predictors of radiation response in glioblastoma.
    Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):704-10. PubMed ID: 15978739
    [Abstract] [Full Text] [Related]

  • 18. Influence of p53 mutations on prognosis of patients with glioblastoma.
    Shiraishi S, Tada K, Nakamura H, Makino K, Kochi M, Saya H, Kuratsu J, Ushio Y.
    Cancer; 2002 Jul 15; 95(2):249-57. PubMed ID: 12124823
    [Abstract] [Full Text] [Related]

  • 19. TP53 mutations in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Kordek R, Liberski PP.
    Pol J Pathol; 1997 Jul 15; 48(4):221-4. PubMed ID: 9529927
    [Abstract] [Full Text] [Related]

  • 20. High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.
    Jesien-Lewandowicz E, Jesionek-Kupnicka D, Zawlik I, Szybka M, Kulczycka-Wojdala D, Rieske P, Sieruta M, Jaskolski D, Och W, Skowronski W, Sikorska B, Potemski P, Papierz W, Liberski PP, Kordek R.
    Cancer Genet Cytogenet; 2009 Jan 15; 188(2):77-82. PubMed ID: 19100509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.